Onkologie. 2016:10(3):142-145 | DOI: 10.36290/xon.2016.031

Experience in the treatment of advanced HER2 positive breast tumor in University Hospital in Motol

Petra Pokorná
Onkologická klinika FN Motol, Praha

A treatment of breast cancer is undergoing important advances for last years, which lead to improvement of the prognosis and

to extension their overall survival. Two new drugs (pertuzumab and trastuzumab emtansin) have been classified into a practice

for patients with advanced HER2 positive breast tumor. Experiences from the clinical practice confirmed the safety of both preparations

and the profit for the patients.

Keywords: advanced HER2 positive breast tumor, pertuzumab, trastuzumab emtansin

Published: June 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pokorná P. Experience in the treatment of advanced HER2 positive breast tumor in University Hospital in Motol. Onkologie. 2016;10(3):142-145. doi: 10.36290/xon.2016.031.
Download citation

References

  1. http://www.linkos.cz/dohody-s-platci-pece/dohoda-ceske-onkologicke-spolecnosti-cls-jep-s-vzp-cr-na-postupu-pri-posuzovani-uhradovych-podminek-u-algoritmu-lecby-her2-pozitivniho-metastazujiciho-karcinomu-prsu/




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.